Dr. Mohan is a Seasoned Pharmaceutical Veteran with more than 30 years of results-driven experience that includes establishing Orbicular and driving it through its early and growth phase. Dr. Mohan founded Orbicular and is serving as the Managing Director. Prior to founding Orbicular, Dr. Mohan served as the Chief Scientific Officer at Strides where he played a key role to bring an overall transformational change in the organization.
Dr. Mohan, early in his career, has worked in reputed companies like Lupin Laboratories Ltd., Astra Zeneca , Ranbaxy Laboratories Limited where he gained extensive experience in handling research activities of products for Regulated Markets like U.S.A, Europe, South Africa, Canada, Brazil and Australia. He later moved to Dr.Reddy’s as the Global Vice President - R&D where he played a pivotal role transforming the company into High Speed-High Value Generic Engine, ramping-up the ANDAs / Global filings and has delivered successfully to business demand with global business development focus.
Dr. Mohan has a PhD in Pharmaceutics, holds 18 U.S. Patent’s, 20 PCT applications to his credit and is an active member in many Professional Associations.
Dr. Hiren has a proven track record over the past 18 Years in the pharmaceutical Industry. Dr. Hiren co-founded Orbicular and is spearheading Orbicular to its next growth orbit as the President of the company . Dr. Hiren is a passionate researcher at heart and heads the Ophthalmics and Parenterals wing at Orbicular apart from handling the business operations. Prior to joining Orbicular, Dr. Hiren was heading Formulation Development for Strides as the Asst. Vice President.
Dr. Hiren has spent a decade and a half in various reputed companies like Dr. Reddy’s, Fresinius Kabi, Dabur, Astron and Zydus Cadila. His experience spans predominantly across the entire injectable end-to-end product development and manufacturing landscape ranging from Liquid, Suspension, Lyophilized, Cytotoxic, Non Cytotoxic, Synthetic protein and ophthalmic formulations focused for the US and Europe markets.
Dr. Hiren has a PhD in Pharmaceutics, holds 7 U.S. Patent’s, PCT applications to his credit.
Rahul has a proven performance credentials in his 17+ years of experience in pharmaceutical industry. Rahul heads the dermatology Joint Venture between Orbicular and Alembic. He has been instrumental in setting up the entire end-to-end capability for dermatology delivery and has integrated various functions like R&D, Regulatory, Plant Operations, Quality assurance, Quality control. His quest for perfection and relentless focus has set the operations on its track within one year of its inception. Prior to joining Orbicular, Rahul was heading the Research and development as the Associate Director for Orchid.
Rahul has spent more than a decade in companies like Dr. Reddy’s and Zydus Cadila where he gained expertise predominantly in the topical and solid oral dosage form spanning across delayed release, extended release, orally disintegrating and chewable tablets and capsules for US and Europe markets.
Rahul has a Masters in Pharmaceutics, holds 12 U.S. Patent’s, PCT applications and research articles to his credit.
Dr. Bhavesh has a established strong credentials in his 17+ years of experience in pharmaceutical industry. Dr. Bhavesh heads the Complex Injectable vertical at Orbicular. He leads the team of highly accomplished scientific talent to deliver various complex and niche injectable formats like Long acting depot injections ranging from microspheres, Liposomes, Nano suspensions and device based peptide injections. His utmost curiosity and quest for innovation has resulted in an novel 505(b)(2) portfolio which delivers added benefits to the end user. Prior to joining Orbicular, Dr. Bhavesh was General Manager of Research and Development at Mylan.
Dr. Bhavesh has spent more than a decade in companies like Dr. Reddys, Astron, Wockhardt and Dabur. His passion for research has helped him expand his horizons across Liquid, Lyophilized and Microsphere Injectables, Ophthalmics, Dry Powder Inhalers and Solid orals for the US and Europe markets. His strong scientific skills and passion for business gives him an edge with complete end-to-eng visibility, right from due diligence on product selection to product launch activities.
Dr. Bhavesh has a PhD in Pharmaceutics, holds more than 10 U.S. Patent’s, PCT applications and research articles to his credit.